141 related articles for article (PubMed ID: 36495345)
1. B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.
Zhang X; Liu H; Wang H; Zhao R; Lu Q; Liu Y; Han Y; LuluRen ; Pan H; Han W
Cell Mol Life Sci; 2022 Dec; 80(1):8. PubMed ID: 36495345
[TBL] [Abstract][Full Text] [Related]
2. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.
Zhang H; Su X; Burley SK; Zheng XFS
Theranostics; 2022; 12(7):3518-3533. PubMed ID: 35547764
[No Abstract] [Full Text] [Related]
3. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
Molecules; 2019 May; 24(10):. PubMed ID: 31137633
[TBL] [Abstract][Full Text] [Related]
4. METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma.
Lin Y; Wei X; Jian Z; Zhang X
Cancer Med; 2020 Apr; 9(8):2859-2867. PubMed ID: 32068977
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling.
Liu F; Zhang W; Yang F; Feng T; Zhou M; Yu Y; Yu X; Zhao W; Yi F; Tang W; Lu Y
Sci Rep; 2016 Feb; 6():21260. PubMed ID: 26879559
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling.
Fang G; Zhang P; Liu J; Zhang X; Zhu X; Li R; Wang H
Cancer Lett; 2019 Oct; 463():11-26. PubMed ID: 31404613
[TBL] [Abstract][Full Text] [Related]
7. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation.
Dong Z; Qi R; Guo X; Zhao X; Li Y; Zeng Z; Bai W; Chang X; Hao L; Chen Y; Lou M; Li Z; Lu Y
Biochem Biophys Res Commun; 2017 Jan; 483(1):630-637. PubMed ID: 27998765
[TBL] [Abstract][Full Text] [Related]
8. MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR.
Chang X; Tian C; Jia Y; Cai Y; Yan P
BMC Cancer; 2023 Feb; 23(1):176. PubMed ID: 36809979
[TBL] [Abstract][Full Text] [Related]
9. A functional loop between YTH domain family protein YTHDF3 mediated m
Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J
J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428
[TBL] [Abstract][Full Text] [Related]
10. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.
Lu C; Fang S; Weng Q; Lv X; Meng M; Zhu J; Zheng L; Hu Y; Gao Y; Wu X; Mao J; Tang B; Zhao Z; Huang L; Ji J
Cell Commun Signal; 2020 Jun; 18(1):97. PubMed ID: 32576292
[TBL] [Abstract][Full Text] [Related]
12. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
13. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
[TBL] [Abstract][Full Text] [Related]
14. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
[No Abstract] [Full Text] [Related]
15. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway.
Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A
Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
17. Degradation of helicase-like transcription factor (HLTF) by β-TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis.
Tan Y; Wu D; Liu ZY; Yu HQ; Zheng XR; Lin XT; Bie P; Zhang LD; Xie CM
J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36822623
[TBL] [Abstract][Full Text] [Related]
18. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
[TBL] [Abstract][Full Text] [Related]
19. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
20. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
